The Swedish chief epidemiologist Anders Tegnell plans to move to the World Health Organisation (WHO) in Geneva.
Deep learning medical imaging specialist Qure.ai raises $40m from healthcare investors Novo Holdings and HealthQuad
While the Nasdaq Biotechnology index saw a huge uplift during the pandemic (+ 77% since March 2020 until reaching a peak in August 2021), it lost 27% during the last six months vs a 11%/4% decline for the Nasdaq Composite and the S&P 500, respectively
Sanofi and IGM Biosciences have entered into a broad antibody discovery collaboration that could bring in IGM $6bn if all milestones are met.
XNK Therapeutics AB has secured a private placement of €12.75m led by Flerie Invest AB to finance Phase II development of CellProtect + Isatuximab in multiple myeloma.
Data Management has been a hotbed for development and innovation, correlating primarily with
the changing digital landscape. Clinical trial management has been significantly impacted, with the
electronic data capture and GDPR-compliance-led industry now unrecognisable from the paper-document administration methods of the past. This development process extends beyond COVID-19 and has a
noticeable impact on clinical trials.
The SARS-CoV-2 virus global outbreak generated a need for fast and reliable large-scale testing. One of the main bottlenecks of the PCR test is the laborious and time-consuming molecular method for viral genetic material extraction. BioEcho Life Sciences, together with Hamilton and the German diagnostics laboratory Labor Dr. Fenner und Kollegen developed an automated workflow for 96- and 48-well plate formats.
ADCs have huge potential in treating challenging diseases such as cancer. However, it is essential that all necessary equipment, steps, and precautions are in place to en¬sure their safe handling.
CSL Behring has filed for accelerated approval of the first hemophilia B gene therapy in Europe.
Maja Neiman is the first Science Relations Manager at SwedenBIO. The biotechnologist started her work at the end of March.